Journal Article10.1042/CS0960513
Glucocorticoids and insulin resistance: old hormones, new targets
Robert Andrews,Brian R. Walker +1 more
749
TL;DR: Evidence from human studies that glucocorticoids make an important contribution to the pathophysiology of insulin resistance in the population is described.
read more
Abstract: Insulin resistance has been proposed as a mediator of the association between risk factors for cardiovascular disease in the population. The clinical syndrome of glucocorticoid excess (Cushing's syndrome) is associated with glucose intolerance, obesity and hypertension. By opposing the actions of insulin, glucocorticoids could contribute to insulin resistance and its association with other cardiovascular risk factors. In this review, we describe briefly the known mechanisms of insulin resistance and highlight the potential mechanisms for the effect of glucocorticoids. We then discuss factors which modulate the influence of glucocorticoids on insulin sensitivity; this highlights a novel therapeutic strategy to manipulate glucocorticoid action which may prove to be a useful tool in treating subjects with insulin resistance. Finally, we describe evidence from human studies that glucocorticoids make an important contribution to the pathophysiology of insulin resistance in the population.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Mechanisms involved in the side effects of glucocorticoids
TL;DR: This review summarizes the current knowledge of the most important GC-mediated side effects from a clinical to a molecular perspective and should be helpful in predicting the potential advantages of selective GR agonists in comparison to classical GCs.
1.8K
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.
TL;DR: The hypothesis that users of exogenous glucocorticoids have an increased risk for cardiovascular disease was tested, and it was hypothesized that high doses will be associated with cardiovascular disease, while doses equivalent to or below the physiologic range of endogenous glucOCorticoid secretion may be compensated for by decreased cortisol levels and will not incur excessive risk.
755
ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents
Elizabeth J. Mayer-Davis,Anna R. Kahkoska,Craig Jefferies,Dana Dabelea,Naby Balde,Chun Xiu Gong,Pablo Aschner,Maria E. Craig,Maria E. Craig +8 more
TL;DR: A marked elevation of the BGL confirms the diagnosis of diabetes, including a random plasma glucose concentration ≥11.1 mmol/L (200 mg/dl) or fasting plasma glucose ≥7.0 mmol/l (≥126 mg/DL) in the presence of overt symptoms.
671
Regulation of Glucose Homeostasis by Glucocorticoids.
TL;DR: The major glucocorticoid effect on glucose homeostasis is to preserve plasma glucose for brain during stress, as transiently raising blood glucose is important to promote maximal brain function.
612
Regulation of adipocytokines and insulin resistance.
Mathias Fasshauer,R. Paschke +1 more
TL;DR: This work summarises the current knowledge on how major adipocyte-secreted proteins are regulated by hormones and drugs influencing insulin sensitivity and discusses its implications for insulin resistance and obesity.
References
Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.
TL;DR: In national samples of 10 year olds and adults in Britain systolic blood pressure was inversely related to birth weight, which suggests that the intrauterine environment influences blood pressure during adult life.
2.4K
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
TL;DR: Continuously elevated levels of plasma FFAs may play a key role in the pathogenesis of NIDDM in predisposed individuals by impairing peripheral glucose utilization and by promoting hepatic glucose overproduction.
1.8K
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
TL;DR: The presence of the enzyme 11 beta-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs, means that these analogs cannot bind to mineralocorticoid receptors.
1.6K
LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR
C. R. W. Edwards,D. Burt,M.A. Mcintyre,E.R. de Kloet,Paul M. Stewart,Lawrence P. Brett,W. Sutanto,Carl Monder +7 more
TL;DR: Findings seem to explain why sodium retention, hypokalaemia, and hypertension develop in subjects with congenital deficiency of 11 beta-OHSD and those in whom the enzyme has been inhibited by liquorice.
1.1K
Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities
TL;DR: Interactions between diurnal cortisol secretion related to perceived stress and anthropometric, endocrine, metabolic, and hemodynamic variables seem to occur with apparently normal regulation of the HPA axis.